These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15709072)

  • 1. Assuring effective malaria treatment in Africa: drug efficacy is necessary but not sufficient.
    Durrheim DN; Williams HA
    J Epidemiol Community Health; 2005 Mar; 59(3):178-9. PubMed ID: 15709072
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloroquine-resistant malaria in Malawi.
    Muula AS
    N Engl J Med; 2007 Feb; 356(8):868-9; author reply 869. PubMed ID: 17323453
    [No Abstract]   [Full Text] [Related]  

  • 3. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The status of malaria chemoresistance in Africa].
    Le Bras J
    Med Trop (Mars); 1995; 55(4 Suppl):9-13. PubMed ID: 8649277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
    Ogbonna A; Uneke CJ
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):621-7. PubMed ID: 18499204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.
    Watkins WM; Sibley CH; Hastings IM
    Am J Trop Med Hyg; 2005 Feb; 72(2):163-73. PubMed ID: 15741553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread and evolution of Plasmodium falciparum drug resistance.
    Mita T; Tanabe K; Kita K
    Parasitol Int; 2009 Sep; 58(3):201-9. PubMed ID: 19393762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
    Berry A; Senescau A; Lelièvre J; Benoit-Vical F; Fabre R; Marchou B; Magnaval JF
    Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):986-8. PubMed ID: 16690094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of falciparum malaria].
    Kager PA
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2192-4. PubMed ID: 17969567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
    Degefa T
    Ethiop Med J; 2004 Jan; 42(1):35-9. PubMed ID: 15884275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the burden of childhood malaria in Africa: the role of improved.
    Rafael ME; Taylor T; Magill A; Lim YW; Girosi F; Allan R
    Nature; 2006 Nov; 444 Suppl 1():39-48. PubMed ID: 17159893
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania.
    Enevold A
    Parassitologia; 2006 Dec; 48(4):547-51. PubMed ID: 17688175
    [No Abstract]   [Full Text] [Related]  

  • 16. Artemisinin resistance in Plasmodium falciparum malaria.
    Htut ZW
    N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria in 2002.
    Greenwood B; Mutabingwa T
    Nature; 2002 Feb; 415(6872):670-2. PubMed ID: 11832954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
    Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K
    Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.